The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
about
The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The -137G/C Polymorphism in In ...... emia Risk in Turkish Patients.
@en
The -137G/C Polymorphism in In ...... emia Risk in Turkish Patients.
@nl
type
label
The -137G/C Polymorphism in In ...... emia Risk in Turkish Patients.
@en
The -137G/C Polymorphism in In ...... emia Risk in Turkish Patients.
@nl
prefLabel
The -137G/C Polymorphism in In ...... emia Risk in Turkish Patients.
@en
The -137G/C Polymorphism in In ...... emia Risk in Turkish Patients.
@nl
P2093
P2860
P356
P1476
The -137G/C Polymorphism in In ...... emia Risk in Turkish Patients.
@en
P2093
Ferit Avcu
Gökhan Özgür
Meral Sarper
Pelin Mutlu
Serap Yalçın
Türker Çetin
P2860
P304
P356
10.4274/TJH.2014.0126
P577
2014-05-21T00:00:00Z